| [1]Shentu J,Wu J,Song W,et al.Chitosan microspheres as immobilized dye affinity support for catalase adsorption[J].Int J BiolMacromol,2005,37(1-2):42-46[2]Li P,Wang Y,Zeng F,et al.Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells[J].Carbohydr Res,2011,346(6):801-806[3]Assaraf YG,Leamon CP,Reddy JA.The folate receptor as a rational therapeutic target for personalized cancer treatment[J].Drug Resist Updat,2014,17(4-6):89-95[4]Li TS,Yawata T,Honke K.Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy[J].Eur J Pharm Sci,2014,52:48-61[5]Pliml J,?orm F.Synthesis of a 2-deoxy-D-ribofuranosyl-5-azacytosine[J].Coll Czech ChemCommun,1964,29(10):2576-2578[6]Sorm F,Vesely J.Effect of 5-aza-2'-deoxycytidine against leukemic and hemopoietic t4s in AKR mice[J].Neoplasma,1968,15(4):339-343[7]Appleton K,Mackay HJ,Judson I,et al.Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors[J].J ClinOncol,2007,25(29):4603-4609[8]Glasspool RM,Brown R,Gore ME,et al.A randomised,phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent,partially platinum-sensitive ovarian cancer[J].Br J Cancer,2014,110(8):1923-1929[9]Li X,Mei Q,Nie J,et al.Decitabine: a promising epi-immunotherapeutic agent in solid tumors[J].Expert Rev ClinImmunol,2015,11(3):363-375[10]Gnyszka A,Jastrzebski Z,Flis S.DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer[J].Anticancer Res,2013,33(8):2989-2996[11]Bugnicourt L,Ladavière C.Interests of chitosan nanoparticles ionically cross-linked with tripolyphosphate for biomedical applications[J].Progress in Polymer Science,2016,60:1-17[12]Jain A,Thakur K,Sharma G,et al.Fabrication,characterization and cytotoxicity studies of ionically cross-linked docetaxel loaded chitosan nanoparticles[J].CarbohydrPolym,2016,137:65-74[13]Prabaharan M.Chitosan-based nanoparticles for tumor-targeted drug delivery[J].Int J BiolMacromol,2015,72:1313-1322[14]徐华生,黄旋平,林曦.地西他滨对人鳞状上皮舌癌SCC-9细胞p16基因甲基化状态及mRNA和蛋白表达的影响与意义[J].实用医学杂志,2016,32(16):2613-2616[15]Lai C,Yu X,Zhuo H,et al.Anti-tumor immune response of folate-conjugated chitosan nanoparticles containing the IP-10 gene in mice with hepatocellular carcinoma[J].J Biomed Nanotechnol,2014,10(12):3576-3589[16]Gaspar V M,Costa E C,Queiroz J A,et al.Folate-targeted multifunctional amino acid-chitosan nanoparticles for improved cancer therapy[J].Pharmaceutical Research,2015,32(2):562-577[17]Dhas N L,Ige P P,Kudarha R R.Design,optimization and in-vitro study of folic acid conjugated-chitosan functionalized PLGA nanoparticle for delivery of bicalutamide in prostate cancer[J].Powder Technology,2015,283:234-245[18]Polyák A,Hajdu I,Bodnár M,et al.Folate receptor targeted self-assembled chitosan-based nanoparticles for SPECT/CT imaging: demonstrating a preclinical proof of concept[J].Int J Pharm,2014,474(1-2):91-94[19]Wang F,Yang S,Hua D,et al.A novel preparation method of paclitaxcel-loaded folate-modified chitosan microparticles and in vitro evaluation[J].J BiomaterSciPolym Ed,2016,27(3):276-289[20]Xu S,Xu Q,Zhou J,et al.Preparation and characterization of folate-chitosan-gemcitabine core-shell nanoparticles for potential tumor-targeted drug delivery[J].J NanosciNanotechnol,2013,13(1):129-138 |
